Document is current
Any future updates will be listed below
-
Authors
Omilian, Angela R.
Mendicino, Lucas
George, Anthony
Darabnoushtehrani, Tina
Ondracek, Rochelle Payne
Bshara, Wiam
Hong, Chi-Chen
Qin, Bo
Bandera, Elisa V.
Khoury, Thaer
Cannioto, Rikki
Yao, Song
Ambrosone, Christine B.
-
Funding
Funding for this research was provided by:
National Cancer Institute (R03 CA238792)
National Cancer Institute (R01 CA185623)
National Cancer Institute (R01 CA185623)
National Cancer Institute (R01 CA247281)
National Cancer Institute (R01 CA247281)
National Institute on Minority Health and Health Disparities (R00 MD013300)
Centers for Disease Control and Prevention (NU5U58DP006279-02-00)
Breast Cancer Research Foundation
- License Information
-
More Information
Article History
Received: 12 February 2025
Accepted: 12 June 2025
First Online: 1 July 2025
Competing interests
: E.V.B. served as a member of Pfizer’s Advisory Board to enhance minority participation in clinical trials (7/2021-8/2023). The other authors declare no potential conflicts of interest.
